Research/art/teacher profile of a person
Name and surname:
prof. MUDr. Stanislav Šutovský, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Sutovsky
I.2 - Name
Stanislav
I.3 - Degrees
prof. MD. PhD.
I.4 - Year of birth
1973
I.5 - Name of the workplace
Comenius University in Bratislava, Faculty of Medicine, First Department of Neurology
I.6 - Address of the workplace
Mickiewiczova 13, 81369, Bratislava
I.7 - Position
University teacher - Professor
I.8 - E-mail address
sutovsky.stanislav@gmail.com
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/3386
I.10 - Name of the study field in which a person works at the university
Neurology
I.11 - ORCID iD
0000-0002-8301-9342

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
1997
II.c - Study field and programme
General Medicine
II.2 - Second degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2007
II.c - Study field and programme
Neurology
II.3 - Third degree of higher education
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2008
II.c - Study field and programme
Neurology
II.4 - Associate professor
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2015
II.c - Study field and programme
Neurology
II.5 - Professor
II.a - Name of the university or institution
Comenius University in Bratislava, Faculty of Medicine
II.b - Year
2023
II.c - Study field and programme
Neurology
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Assistant, Associate Professor, Professor Comenius University in Bratislava, Faculty of Medicine, First Department of Neurology 2003 - until now
neurologist Department of Neurology, St. Cyril and Method Hospital, 2000 - 2003
scientist Max-Planck Institute for Structural Molecular Biology, Hamburg, Germany 1999 - 2000
Study fellowship Department of Neurology, Manchester Royal Infirmary, Manchester, Great Britain 1999
scientist Institute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, Bratislava 1997 - 1998

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Certificate, English language Language school, Bratislava, Slovakia. 1998

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Neurology General Medicine I. + II. General Medicine
Neurology Dentistry I.+ II. Dentistry
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
Neurology I.+ II. General Medicine
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
4
V.4.c - Dissertation (third degree)
0
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
25
V.4.c - Dissertation (third degree)
2
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Medical Neuroscience all PhD study programmes at FMCU III. General Medicine

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
142
VI.1.b - Over the last six years
65
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
82
VI.1.b - Over the last six years
48
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
435
VI.1.b - Over the last six years
240
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
341
VI.1.b - Over the last six years
216
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
84
VI.1.b - Over the last six years
63
VI.2 - The most significant research/artistic/other outputs
1

Novak P, Kovacech B, Katina S, Schmidt R, Scheltens P, Kontsekova E, Ropele S, Fialova L, Kramberger M, Paulenka-Ivanovova N, Smisek M, Hanes J, Stevens E, Kovac A, Sutovsky S, Parrak V, Koson P, Prcina M, Galba J, Cente M, Hromadka T, Filipcik P, Piestansky J, Samcova M, Prenn-Gologranc C, Sivak R, Froelich L, Fresser M, Rakusa M, Harrison J, Hort J, Otto M, Tosun D, Ondrus M, Winblad B, Novak M, Zilka N. ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease. Nat Aging. 2021 Jun;1(6):521-534. doi: 10.1038/s43587-021-00070-2. (Q1, IF=17,1)

2

Sutovsky S, Petrovic R, Fischerova M, et al. Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer's Disease and Their Epistatic Interaction. J Alzheimers Dis. 2020;77(3):1095-1105. doi:10.3233/JAD-200321 (Q1, IF=4,1)

3

Jessen F, Kramberger MG, Angioni D, Aarsland D, Balasa M, Bennys K, Boada M, Boban M, Chincarini A, Exalto L, Felbecker A, Fliessbach K, Frisoni GB, Garza-Martínez AJ, Grimmer T, Hanseeuw B, Hort J, Ivanoiu A, Klöppel S, Krajcovicova L, McGuinness B, Mecocci P, de Mendonca A, Nous A, Ousset PJ, Paquet C, Perneczky R, Peters O, Tabuas-Pereira M, Piazza F, Plantone D, Riverol M, Ruiz A, Sacco G, Santana I, Scarmeas N, Solje E, Stefanova E, Sutovsky S, van der Flier W, Welsh T, Wimo A, Winblad B, Frölich L, Engelborghs S. Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators. J Prev Alzheimers Dis. 2024;11(5):1212-1218. doi: 10.14283/jpad.2024.153. (Q1, IF=6,9)

4

Sutovsky S, Smolek T, Turcani P, Petrovic R, Brandoburova P, Jadhav S, Novak P, Attems J, Zilka N. Neuropathology and biochemistry of early onset familial Alzheimer's disease caused by presenilin-1 missense mutation Thr116Asn. J Neural Transm (Vienna). 2018; 125(6):965-976. doi: 10.1007/s00702-018-1850-z. (Q2, IF=2,90)

5

Sutovský S, Petrovic R, Chandoga J, Turcáni P. Adult onset cerebral form of X-linked adrenoleukodystrophy with dementia of frontal lobe type with new L160P mutation in ABCD1 gene. J Neurol Sci. 2007 Dec 15;263(1-2):149-53. doi: 10.1016/j.jns.2007.01.082. (Q2, IF =2,31)

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Novak P, Kovacech B, Katina S, Schmidt R, Scheltens P, Kontsekova E, Ropele S, Fialova L, Kramberger M, Paulenka-Ivanovova N, Smisek M, Hanes J, Stevens E, Kovac A, Sutovsky S, Parrak V, Koson P, Prcina M, Galba J, Cente M, Hromadka T, Filipcik P, Piestansky J, Samcova M, Prenn-Gologranc C, Sivak R, Froelich L, Fresser M, Rakusa M, Harrison J, Hort J, Otto M, Tosun D, Ondrus M, Winblad B, Novak M, Zilka N. ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease. Nat Aging. 2021 Jun;1(6):521-534. doi: 10.1038/s43587-021-00070-2. (Q1, IF=17,1)

2

Sutovsky S, Petrovic R, Fischerova M, et al. Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer's Disease and Their Epistatic Interaction. J Alzheimers Dis. 2020;77(3):1095-1105. doi:10.3233/JAD-200321 (Q1, IF=4,1)

3

Jessen F, Kramberger MG, Angioni D, Aarsland D, Balasa M, Bennys K, Boada M, Boban M, Chincarini A, Exalto L, Felbecker A, Fliessbach K, Frisoni GB, Garza-Martínez AJ, Grimmer T, Hanseeuw B, Hort J, Ivanoiu A, Klöppel S, Krajcovicova L, McGuinness B, Mecocci P, de Mendonca A, Nous A, Ousset PJ, Paquet C, Perneczky R, Peters O, Tabuas-Pereira M, Piazza F, Plantone D, Riverol M, Ruiz A, Sacco G, Santana I, Scarmeas N, Solje E, Stefanova E, Sutovsky S, van der Flier W, Welsh T, Wimo A, Winblad B, Frölich L, Engelborghs S. Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators. J Prev Alzheimers Dis. 2024;11(5):1212-1218. doi: 10.14283/jpad.2024.153. (Q1, IF=6,9)

4

Stevens RH, Zhang H, Kajsik M, Płoski R, Rydzanicz M, Sabaka P, Šutovský S. Successful use of a phage endolysin for treatment of chronic pelvic pain syndrome/chronic bacterial prostatitis. Front Med (Lausanne). 2023 Aug 15;10:1238147. doi: 10.3389/fmed.2023.1238147. (Q1, IF=3,1)

5

Hnilicova P, Kantorova E, Sutovsky S, Grofik M, Zelenak K, Kurca E, Zilka N, Parvanovova P, Kolisek M. Imaging Methods Applicable in the Diagnostics of Alzheimer's Disease, Considering the Involvement of Insulin Resistance. Int J Mol Sci. 2023 Feb 7;24(4):3325. doi: 10.3390/ijms24043325. (Q1, IF=6.20)

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol. 2023;19(12):715-736. doi:10.1038/s41582-023-00883-2

2

Galasko D. Active immunization in Alzheimer's disease. Nat Aging. 2021 Jun;1(6):493-495. doi: 10.1038 /s43587-021-00076-w.

3

Kantarci K. 2021 marks a new era for Alzheimer's therapeutics. Lancet Neurol. 2022 Jan;21(1):3-4. doi: 10.1016/S1474-4422(21)00412-9.

4

Imbimbo BP, Ippati S, Watling M, et al. A critical appraisal of tau targeting therapies for primary and secondary tauopathies. Alzheimers

Dement. 2022 May;18(5):1008-1037. doi: 10.1002/alz.12453.

5

Ten Kate M, Barkhof F, Schwarz AJ. Consistency between Treatment Effects on Clinical and Brain Atrophy Outcomes in Alzheimer's Disease Trials. J Prev Alzheimers Dis. 2024;11(1):38-47. doi:10.14283/jpad.2023.92

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

2016-2019: APVV-15-0253 Molecular mediators of the effects of physical activity and carnosine in patients with preclinical and early stages of neurodegenerative diseases - Co-Investigator

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
Co - guarantor of the PhD programme psychiatry Faculty of Medicine, Comenius University in Bratislava 2016 - 2021
Co - guarantor of the PhD programme Medical Neuroscience Faculty of Medicine, Comenius University in Bratislava 2021 - present
Expert of the Ministry of Health of the Slovak Republic for dementia within the platform Alzheimer Europe and Governmental Expert Group for Dementia Alzheimer Europe; Governmental Expert Group for Dementia 2017 - present
EAN Scientific Panel on ALS & FTD – member, representative of the Slovak Republic European Academy of Neurology 2018 - present
European Alzheimer's Disease Consortium (EADC) – member, representative of the Slovak Republic European Alzheimer's Disease Consortium (EADC) 2022 - present

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
University of Manchester, Manchester Royal Infirmary Oxford Rd, Manchester, M13 9PL, UK 1999 visiting fellow

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Slovak neurologic society – member,

European Academy of Neurology – member,

Alzheimer‘s Association – member

Alzheimer Europe – member

Date of last update
2025-01-20